News Focus
News Focus
Post# of 257295
Next 10
Followers 85
Posts 12814
Boards Moderated 0
Alias Born 07/25/2008

Re: bladerunner1717 post# 151327

Saturday, 10/27/2012 9:54:49 AM

Saturday, October 27, 2012 9:54:49 AM

Post# of 257295
Harvey has also highlighted numerous times the much stronger efficacy of Ponatinib after the failure on one TKI, verses two or three. With these patients still on trial, and no further progression, this speaks volumes.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today